A detailed history of Financial Management Professionals, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 31 shares of BIIB stock, worth $4,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 11 181.82%
Holding current value
$4,619
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$189.07 - $236.8 $3,781 - $4,736
20 Added 181.82%
31 $6,000
Q2 2024

Jul 12, 2024

BUY
$190.52 - $236.72 $952 - $1,183
5 Added 83.33%
11 $3,000
Q1 2024

Apr 16, 2024

BUY
$212.02 - $267.71 $1,272 - $1,606
6 New
6 $1,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.